Resources Archives

March 20, 2025

Bringing Clinical Trials to CLL and Blood Cancer Patients

By helping with support, logistics, and the cost of travel, Mayo Clinic increased the accrual of blood cancer trials, especially for rural patients.

March 20, 2025

Insurers Reject One in Four Oral Blood Cancer Prescriptions

Specialty oral anticancer drugs have drastically improved outcomes for CLL, but they come at considerable cost, and not all patients have access.

March 20, 2025

Blacks, Hispanics, and Females Enroll Less in CLL Trials

Disparities persist as Blacks, Hispanics, and females are underrepresented in clinical trials for CLL and other blood cancers.

March 20, 2025

Novel Therapies Do Not Increase Second Cancers in CLL

Unlike chemoimmunotherapy, new oral therapies don’t increase the risk of other cancers versus active surveillance in CLL patients.

March 20, 2025

Quality of Life, Medication Adherence, and Cost in CLL

CLL patients who take oral cancer drugs frontline experience significant financial toxicity and less-than-ideal medication adherence.

December 2, 2024

Increasing Diversity in CLL Clinical Trials

Minority patients are underrepresented in hematology clinical trials, but this is improved by using nontraditional trial sites in other counties.

November 6, 2024

CLL Society Presents ECCO Initiative to Increase Health Equity

At Lymphoma Coalition’s 2024 Global Summit, Fernando Parra Chong presented on CLL Society’s Equitable Community Care Outreach (ECCO) Initiative.

September 23, 2024

How CLL Impacts Different Racial and Ethnic Populations

Regardless of race, when individuals with chronic lymphocytic leukemia (CLL) have equal access to cancer care, overall survival is similar for all patients.

August 16, 2024

Chronic Lymphocytic Leukemia in Adolescents and Young Adults

Though chronic lymphocytic leukemia (CLL) is rare in younger patients, adolescents and young adults with CLL have a better prognosis than older patients.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Resources

Bringing Clinical Trials to CLL and Blood Cancer Patients

Insurers Reject One in Four Oral Blood Cancer Prescriptions

Blacks, Hispanics, and Females Enroll Less in CLL Trials

Novel Therapies Do Not Increase Second Cancers in CLL

Quality of Life, Medication Adherence, and Cost in CLL

Increasing Diversity in CLL Clinical Trials

CLL Society Presents ECCO Initiative to Increase Health Equity

How CLL Impacts Different Racial and Ethnic Populations

Chronic Lymphocytic Leukemia in Adolescents and Young Adults

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT CLL SOCIETY

CONTACT